Solid lipid nanoparticles (SLNs), loaded and unloaded with praziquantel (PRZ-load SLN and PRZ-unload SLN) were prepared by two different procedures: (a) oil-in-water hot microemulsion method, obtaining at 70 °C an optically transparent blend composed of surfactant, co-surfactant, and water; and (b) oil-in-water microemulsion method, dissolving the lipid in an immiscible organic solvent, emulsified in water containing surfactants and co-surfactant, and then evaporated under reduced pressure at 50 °C. The mean diameter, polydispersity index (PdI), and zeta potential were 187 to 665 nm, 0.300 to 0.655, and −25 to −28 mV respectively, depending on the preparation method. The components, binary mixture, SLNs loaded and unloaded with PRZ, and physical mixture were evaluated by differential scanning calorimetry (DSC) and thermogravimetry (TG). The non-isothermal isoconversional Flynn-Wall–Ozawa method was used to determine the kinetic parameters associated with the thermal decomposition of the samples. The experimental data indicated a linear relationship between the apparent activation energy E and the pre-exponential factor A, also called the kinetic compensation effect (KCE), allowing us to determine the stability with respect to the preparation method. Loading with PRZ increased the thermal stability of the SLNs.
1. World Health Organization. Schistosomiasis. http://www.who.int/schistosomiasis/en. Accessed 22 Jan 2011.
2. Jeziorski, MC, Greenberg, RM. 2006 Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. Int J Parasitol. 36: 6 625–632. .
3. USP 31, NF 23. The United States Pharmacopeia and National Formulary. 2008; 3056–7.
4. The Merck Index, Merck & Co. Inc., 13th ed. New York: Whitehouse Station; 2001.
5. Passerini, N, Albertici, B, Perissuti, B, Rodriguez, L. 2006 Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel. Int J Pharm. 318: 1–2 92–102. .
6. Hu, FQ, Zhang, Y, Du, YZ, Yuan, H. 2008 Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. Int J Pharm. 348: 1–2 146–152. .
7. Müller, RH, Runge, SA, Ravelli, V, Thünemann, F, Mehnert, W, Souto, EB. 2008 Cyclosporine-loaded solid lipid nanoparticles (SLN®): Drug–lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm. 68: 3 535–544. .
8. Joshi, M, Patravale, V. 2008 Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm. 346: 1–2 124–132. .
9. Gasco MR . Method for producing solid lipid microspheres having a narrow size distribution. US Patent 1993;No. 5,250,236.
10. Müller RH , Lucks JS. Medication vehicles made of solid lipid particles (solid lipid nanospheres––SLN). European Patent 1996;No. 0605497.
11. Fricker, G, Kromp, T, Wendel, A, Blume, A, Zirkel, J, Rebmann, H, Setzer, C, Quinkert, RO, Martin, F, Müller-Goymann, C. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010;27:1469–1486. .
12. Kristl, J, Volk, B, Ahlin, P, Gombac, K, Sentjurc, M. 2003 Interactions of solid lipid nanoparticles with membranes and leukocytes studied by EPR. Int J Pharm. 256:133–140. .
13. Kumar, VV, Chandrasekar, D, Ramakrishna, S, Kishan, V, Rao, YM, Diwan, PV. 2007 Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 335:167–175. .
14. Lin, X, Li, X, Zheng, L, Yu, L, Zhang, Q, Liu, W. 2007 Preparation and characterization of monocaprate nanostructured lipid carriers. Colloids and Surf A. 311:106–111. .
15. Muller, RH, Mader, K, Gohla, S. 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 50:161–177. .
16. Radomska-Soukharev, A. 2007 Stability of lipid excipient in solid lipid nanoparticles. Adv Drug Deliver Rev. 59:411–418. .
17. Westesen, K, Bunjes, H. 1995 Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?. Int J Pharm. 115:129–131. .
18. Bunjes, H, Unruh, T. 2007 Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliver Rev. 59:379–402. .
19. Liu, H, Li, S, Wang, Y, Yao, H, Zhang, Y. 2006 Effect of vehicles and enhancers on the topical delivery of cyclosporine A. Int J Pharm. 311:182–186. .
20. Mainardes, RM, Chaud, MV, Gremião, MPD, Evangelista, RC. 2006 Development of praziquantel-loaded PLGA nanoparticles and evaluation of intestinal permeation by the everted gut sac model. J Nanosci Nanotechnol. 6:3057–3061. .
21. Luo, Y, Chen, D, Ren, L, Zhao, X, Qin, J. 2006 Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Release. 114:53–59. .
22. Mehnert, W, Mader, K. 2001 Solid lipid nanoparticles: production, characterization, and applications. Adv Drug Deliver Rev. 47:165–196. .
23. Pedersen, N, Hansen, S, Heydenreich, AV, Kristensen, HG, Poulsen, HS. 2006 Solid lipid nanoparticles can effectively bind DNA streptavidin and biotinylated ligands. Eur J Pharm Biopharm. 62:155–162. .
24. Mendoza, AE, Companero, MA, Mollinedo, F, Blanco-Prieto, MJ. 2009 Lipid nanomedicines for anticancer drug therapy. J Biomed Nanotechnol. 5:323–343. .
25. Brown, ME, Dolimore, D, Galwey, AK. Reactions in the solid state: comprehensive chemical kinetics. Amsterdam: Elsevier; 1980.
26. Flynn, JH, Wall, LA. 1966 General treatment of the thermogravimetry of polymers. J Res Natl Bur Stand A. 70:487–523.
27. Flynn, JH, Wall, J. 1966 A quick direct method for the determination of activation energy from thermogravimetric data. Polym Lett. 4:323–328. .
28. Dahiya, JB, Kumar, K, Muller-Hagedorn, M, Bockhom, H. 2008 Kinetics of isothermal and non-isothermal degradation of cellulose: model-based and model-free methods. Polym Int. 57:722–729. .
29. Doyle, CD. 1962 Estimating isothermal life from thermogravimetric data. J Appl Polym Sci. 6:639–642. .
30. Kissinger, HE. 1957 Reaction kinetics in differential thermal analysis. Anal Chem. 29:1702–1706. .